CHGA and colorectal cancer: CHGA has been approved as a powerful biomarker for the early detection of various digestive system carcinomas, including gastric cancer (Yang and Chung, 2008), pancreatic neuroendocrine tumors (Weisbrod et al., 2013), and colorectal cancer (Zhang et al., 2019).